期刊文献+

白大衣高血压患者血清TNF-α、sIL-2R、IL-6水平的临床意义 被引量:3

The observation of level of tumor necrosis factor α,soluble interleukin 2 receptor and interleukin 6 in serum of white coat hypertension patients
原文传递
导出
摘要 目的 :观察白大衣高血压患者血清肿瘤坏死因子 - α(TNF- α)、可溶性白细胞介素 - 2受体 (s IL- 2 R)与白细胞介素 - 6 (IL- 6 )水平 ,评价其临床意义。方法 :采用酶标法 (EL ISA)测定原发性高血压组 (EH组 ,32例 )、白大衣高血压组 (30例 )及正常血压组 (30例 )血清 TNF-α(ng/ L )、s IL - 2 R(k IU / L )、IL - 6 (ng/ L )水平 ,并测量诊室血压及2 4h动态血压 (ABPM)值。结果 :1诊室血压参数 :EH组及白大衣高血压组收缩压 (SBP)、舒张压 (DBP)明显高于正常血压组 (P <0 .0 1 )。ABPM参数 ,EH组平均日间、平均夜间、平均 2 4h SBP及平均 2 4h DBP均明显高于白大衣高血压组及正常血压组 (P<0 .0 1 )。EH组平均日间、平均夜间 DBP高于白大衣高血压组及正常血压组(P <0 .0 5 )。2 EH组血清 TNF- α,s IL- 2 R,IL- 6水平均高于白大衣高血压组 (P <0 .0 5 )和正常血压组 (P <0 .0 1 )。白大衣高血压组 s IL- 2 R,TNF- α及 IL- 6水平明显高于正常血压组 (P <0 .0 5 ,<0 .0 1 )。结论 :白大衣高血压患者血清细胞因子水平介于 EH者与正常血压者之间 ,反映白大衣高血压时机体已产生免疫调节与自身保护 ,提示白大衣高血压是介于高血压与正常血压之间的临床状态 ,应视为 Objective:To investigate the level of tumor necrosis factor α (TNF α),soluble interleukin 2 receptor (sIL 2R),interleukin 6 (IL 6) in serum of hypertensives (n=32),white coat hypertensives (n=30) and normal blood pressure (BP) controls (n=30).Method:Clinic BP (mmHg) and 24 hour ambulatory blood pressure monitoring (ABPM,mmHg) were performed and the level of TNF α(ng/L),sIL 2R (kIU/L) and IL 6 (ng/L) in serum were determined by enzyme linked immunoscorbent assay (ELISA).Result:①Clinic BP of hypertension patients (SBP 155±12,DBP 98±5) and white coat hypertension patients (SBP 147±3,DBP 97±2) were markedly higher than normal BP controls (SBP 127±6,DBP 78±3) (P< 0.01 ).ABPM data of hypertension (day SBP 148±11,night SBP 134±8,24 h SBP 146±9,24 h DBP 95±4) were markedly higher than those of white coat hypertension (day SBP 126±4,night SBP 112±3,24 h SBP 124±5,24 h DBP 76±6) and those of normal BP controls (day SBP 124±4,night SBP 112±3,24 h SBP 122±3,24 h DBP 75±4) (P< 0.01 ).Day DBP (97±4) and night DBP (86±3) of hypertension patients were higher than those of white coat hypertension (day DBP 81±2,night DBP 71±4) and normal controls (day DBP 79±2,night DBP 68±6)(P< 0.05 ).②The level of TNF α ( 77.98 ± 59.76 ),sIL 2R ( 414.77 ± 185.49 ) and IL 6 ( 39.22 ± 31.93 ) in serum of hypertension patients and TNF α ( 69.50 ± 40.91 ),IL 6 ( 22.21 ± 45.65 ) of white coat hypertension were markedly higher than normal BP controls (TNF α 41.55 ± 36.52 ,sIL 2R 251.64 ± 116.26 ,IL 6 10.05 ± 13.22 ) (P< 0.01 ) .sIL 2R of white coat hypertension patients was higher than that of normal BP controls (P< 0.05 ).Conclusion:The level of cytoleukin in serum of white coat hypertension is between hypertension and normal BP controls.It means the regulation of immune function and self protection have taken place in white coat hypertension as hypertension patients and white coat hypertension is an early clinic stage of hypertension.
机构地区 江苏省老年医院
出处 《临床心血管病杂志》 CSCD 北大核心 2000年第8期352-354,共3页 Journal of Clinical Cardiology
关键词 SIL-2R 白细胞介素-6 白大衣高血压 TNFΑ Tumor necrosis factor α Interleukin 2 receptor Interleukin 6 White coat hypertension
  • 引文网络
  • 相关文献

参考文献5

二级参考文献17

  • 1张木兰,王凌燕,吴金义,王桂兰,杜桂蓉,高庆英.急性心肌梗塞患者外周血sIL-2R含量测定[J].中国免疫学杂志,1993,9(6):376-376. 被引量:8
  • 2董波,宿传平,潘祥林,高洁,朱兴雷,邵建华,潘景韬.心血管疾病中可溶性白细胞介素2受体的检测及应用[J].中华心血管病杂志,1994,22(3):184-185. 被引量:14
  • 3祝之明,中华心血管病杂志,1991年,19卷,217页
  • 4汤健,原癌基因与心血管疾病,1990年
  • 5张维忠,中国高血压杂志,1995年,3卷,119页
  • 6Suzuki H,Shibano k,Okane M,et al.Interferon-gamma modulatesmessenger RNA levels ofc-sis(PDGF-B chain),PDGF-A chin,andIL-1 beta genes in human vascular endothelial cells. American Journal of Pathology . 1989
  • 7Tuttle RS,Boppan DP.Antihyertensive effect of interferon in thespontaneously hypertensive rat. The FASEB Journal . 1990
  • 8Warner SJC,Libby Peter.Human vascular smooth muscle cells:target for and source of tumor necrosis factor. J Immunol . 1989
  • 9Sauro MD.Hadden JW Gamma-interferon corrects aberrant proteinkinase C level and immunosuppression in the spontaneously hypertensive rat Int. J Immunopharmacol . 1992
  • 10Bobik A,Grooms A,Mlliar JA,et al.Growth factor activity of endothelin on vascuhr smooth muscle. A,, J Physiol . 1990

共引文献26

同被引文献31

  • 1[1]Nakao M, Nomura S, Shimosawa T, et al. Blood pressure biofeedback treatment of white-coat hypertension. J Psychosom Res, 2000,48(2):161~169
  • 2[2]Patrick O, Neil A, Eoin O'Brien. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension, 1999,34:267~272
  • 3[3]Muneta S, Kobayshi T, Matsumoto I. Personality characteristics of patients with "white coat" hypertension. Hypertens Res, 1997,20(2):99~104
  • 4[4]Grassi G, Turri C, Vailati S, et al. Muscle and skin sympathetic nerve traffic during the "white coat" effect. Circulation, 1999,100:222~225
  • 5[5]Ryan J M, Howes L G. White coat effect of alcohol. Am J Hypertens, 2000,13(10):1135~1138
  • 6[6]Martinez M A, Garcia-Puig J, Martin J C, et al. Frequency and determinants of white coat hypertension in mild to moderate hypertension:a primary care-based study. Monitorizacion ambulatoria de la presion arterial(MAPA)-area 5 working group. Am J Hypertens, 1999,12(3):251~258
  • 7[7]Strandberg T E, Salomaa V. White coat effect, blood pressure and mortality in men: prospective cohort study. Eur Heart J, 2000,21(20):1714~1718
  • 8[8]Muscholl M W, Hense H W, Brockel U, et al. Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ, 1998,317(7158):565~570
  • 9[9]Rajdeep S K, Roxy S, Avijit L, et al. Cardiovascular outcome in white-coat versus sustained mild hypertension. Circulation, 1998,98:1892~1897
  • 10[10]Soma J, Wideroe T E, Dahl K, et al. Left ventricular systolic and diastolic function assessed with two-dimensional and doppler echocardiography in "white coat" hypertension. J Am Coll Cardiol, 1996,28(1):190~196

引证文献3

二级引证文献6

;
使用帮助 返回顶部